Carson Laura, Price John E
Stormont-Vail Healthcare, Topeka, KS, USA.
Hosp Pharm. 2020 Feb;55(1):69-71. doi: 10.1177/0018578718823739. Epub 2019 Jan 13.
An 83-year-old woman with atrial fibrillation on chronic warfarin therapy was given 4-factor prothrombin complex concentrate to reverse her warfarin for surgery. She had fallen off a step stool at home and fractured her left wrist which initially the surgeon was going to repair surgically. The day after she received 4-factor prothrombin complex concentrate, she developed stroke-like symptoms, National Institutes of Health Stroke Scale (NIHSS) was 14, and met criteria for tissue plasminogen activator (tPA) administration. Tissue plasminogen activator was administered and she was transferred to the intensive care unit (ICU), per hospital protocol. She remained in the ICU for 24 hours for follow-up and monitoring. Her warfarin was restarted and bridged with enoxaparin. She was not a candidate for antiplatelet therapy due to her history of a gastrointestinal (GI) bleed. At discharge, she had no residual effects from her stroke-like symptoms and a magnetic resonance imaging (MRI) of her brain was negative for an acute cerebrovascular accident (CVA).
一名83岁患有心房颤动且长期接受华法林治疗的女性,为进行手术,给予其4因子凝血酶原复合物浓缩剂以逆转华法林的抗凝作用。她在家中从脚凳上摔下,导致左手腕骨折,最初外科医生打算进行手术修复。在她接受4因子凝血酶原复合物浓缩剂后的第二天,出现了类似中风的症状,美国国立卫生研究院卒中量表(NIHSS)评分为14分,符合组织型纤溶酶原激活剂(tPA)的使用标准。按照医院规程,给予了组织型纤溶酶原激活剂治疗,并将她转入重症监护病房(ICU)。她在ICU接受了24小时的随访和监测。重新开始使用华法林,并使用依诺肝素进行桥接抗凝。由于她有胃肠道出血史,不适合接受抗血小板治疗。出院时,她没有类似中风症状的残留影响,脑部磁共振成像(MRI)显示无急性脑血管意外(CVA)。